Financial Results and Presentations FY2026 Interim Results Archives | Aspen Pharmacare

Share Price:

APNASPENAspen Pharmacare Hldgs133580 (0.00%)

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

SENS – DISTRIBUTION OF CIRCULAR TO SHAREHOLDERS AND NOTICE OF GENERAL MEETING

Circular to shareholders – 19 March 2026

Aspen Pharmacare Holdings Limited – Memorandum of Incorporation

Aspen Global Incorporated – Constitution

Annual Financial Statements (including Non-IFRS Financial Information) 2023

Annual Financial Statements (Non-IFRS Financial Information) 2024

Annual Financial Statements (Non-IFRS Financial Information) 2025

Annexure 1 – Combined Historical Financial Information FY 2023, FY 2024 and FY 2025

Our Purpose

Find out more

To improve the health and quality of life of patients.

Our Vision

Find out more

To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.

Our Values

Find out more

Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.

Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912

Medical Careline (South Africa) 0800 118 088

About Aspen

We Care

Careers

Contact Us

ASPEN PHARMACARE HOLDINGS LTD: Switchboard: +27 31 580-8600

Aspen Place, 9 Rydall Vale Park
Douglas Saunders Drive, La Lucia Ridge South Africa

P.O. Box 25125, Gateway, Kwa‑Zulu Natal, 4321, South Africa